MGC Pharma is joining a global Covid-19 World Health Organisation (WHO) taskforce to map and assess research and clinical trials aimed at halting the global pandemic.
The move comes as the Perth-based, ASX-listed medicinal cannabis company announced an expansion of its clinical trial of ArtemiC in Covid-19 patients to India after receiving ethics approval.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.